Pharmacovigilance · 6 min read

Pharmacovigilance in Practice: From Case Receipt to Regulatory Reporting

How an adverse event moves through intake, coding, medical review and submission, and where local safety teams most often lose time.

An adverse event report is simple to describe and surprisingly easy to mishandle. Following one case from receipt to submission shows where a safety system is strong and where it leaks time.

The journey of a case

  1. Receipt and triage: log the report, establish the four minimum criteria (identifiable reporter, identifiable patient, suspect product, adverse event) and start the clock.
  2. Data entry and coding: capture the case in the safety database and code events and products consistently.
  3. Medical review: assess seriousness, causality and expectedness against the reference safety information.
  4. Reporting: submit to the relevant authorities within the required timelines, then follow up for missing information.
  5. Archive and trend: keep the complete audit trail and feed cases into signal detection.

Where time is lost

  • Unclear clock-start: the team cannot say when the company first became aware of the case.
  • Follow-up that waits: queries to reporters sent days after they could have been.
  • Inconsistent coding: the same event coded three ways, which hides signals.
  • Local reports that never reach the global database.

Most delays are process problems, not people problems. A clear definition of day zero, a shared follow-up template and a weekly reconciliation of local and global case counts resolve the majority of them.

Our pharmacovigilance team supports adverse-event reporting, safety-database management and periodic reports across African markets.

Begin

Ready to navigate Africa’s regulatory landscape?

Tell us about your product and target markets. An ECP specialist will respond with a clear next step.